CSI Market
Sign In | Register

Akero Therapeutics Inc (AKRO) Annual Balance Sheets

Annual · GAAP · USD millions
Access AKRO quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Akero Therapeutics Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent340.24
Marketable Securities, Current SH402.84
Cash & Short-term Investments742.00
Prepaid Expense And Other Assets Current27.30
Total Current Assets770.38
Equipment/Property/Plant Net0.00
Long-term investments54.75
Other Assets, Noncurrent1.00
Operating Lease Right Of Use Asset0.76
Total Assets825.89
Liabilities
Accounts Payable, Current AC9.03
Other Liabilities, Current30.73
Total Current Liabilities39.75
Long-term debt35.30
Total Long-term Debt35.30
Derivative Liability, Noncurrent DE0.19
Other liabilities, Noncurrent0.53
Accrued Expenses And Other Current Liabilities30.73
Operating Lease Liability Noncurrent0.53
Total Liabilities75.77
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,575.31
Retained Earnings / Accumulated Deficit-826.16
Other Equity0.95
Common Stockholder's Equity750.11
Total Stockholder's Equity750.11
Liabilities & Stockholder's Equity825.89
4 historic quarters locked

Sign in to unlock the full Akero Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Akero Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20241231)
  • Filed with the SEC: February 28, 2025
  • Source: akro-20241231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-029514

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License